Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

$21.49 +0.10 (+0.48%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$21.47 -0.02 (-0.11%)

As of 05/14/2026 04:56 PM Eastern

FMS vs. NTRA, GH, BTSG, HIMS, and CELC

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? MarketBeat compares Fresenius Medical Care AG & Co. KGaA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fresenius Medical Care AG & Co. KGaA include Natera (NTRA), Guardant Health (GH), BrightSpring Health Services (BTSG), Hims & Hers Health (HIMS), and Celcuity (CELC). These companies are all part of the "healthcare" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Natera?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Natera has a beta of 1.57, indicating that its stock price is 57% more volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Natera had 20 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 25 mentions for Natera and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Natera's score of 0.61 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Natera	8 Very Positive mention(s)	5 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Natera	-9.05%	-14.74%	-10.27%

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 30.27%. Natera has a consensus price target of $256.60, indicating a potential upside of 30.31%. Given Natera's stronger consensus rating and higher probable upside, analysts clearly believe Natera is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.79

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31
Natera	$2.31B	12.23	-$208.16M	-$1.63	N/A

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, institutional ownership, media sentiment and risk.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its stock price is 19% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Guardant Health had 15 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 20 mentions for Guardant Health and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Guardant Health's score of 0.56 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	7 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%
Guardant Health	-40.10%	N/A	-26.42%

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, indicating a potential upside of 30.27%. Guardant Health has a consensus price target of $129.42, indicating a potential upside of 31.18%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31
Guardant Health	$982.02M	13.32	-$416.28M	-$3.39	N/A

Summary

Fresenius Medical Care AG & Co. KGaA and Guardant Health tied by winning 8 of the 16 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, BrightSpring Health Services had 4 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 9 mentions for BrightSpring Health Services and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat BrightSpring Health Services' score of 0.95 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.88	$190.67M	$1.41	41.42
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

BrightSpring Health Services has a beta of 1.71, meaning that its stock price is 71% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

BrightSpring Health Services presently has a consensus price target of $56.29, suggesting a potential downside of 3.62%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, suggesting a potential upside of 30.27%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

In the previous week, Hims & Hers Health had 71 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 76 mentions for Hims & Hers Health and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Hims & Hers Health's score of 0.02 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	18 Very Positive mention(s)	11 Positive mention(s)	10 Neutral mention(s)	23 Negative mention(s)	6 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a beta of 2.43, indicating that its share price is 143% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.37B	2.33	$128.37M	-$0.09	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Hims & Hers Health's net margin of -0.56%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Hims & Hers Health presently has a consensus price target of $29.50, suggesting a potential upside of 21.73%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, suggesting a potential upside of 30.27%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Fresenius Medical Care AG & Co. KGaA beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Celcuity?

Celcuity (NASDAQ:CELC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

In the previous week, Celcuity had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for Celcuity and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.23 beat Celcuity's score of 0.65 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Celcuity has a beta of 0.09, indicating that its share price is 91% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its share price is 19% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.90	11.31

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-203.17%	-52.68%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Celcuity presently has a consensus price target of $134.50, suggesting a potential downside of 0.16%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, suggesting a potential upside of 30.27%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Celcuity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.56

63.3% of Celcuity shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 10 of the 15 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FMS vs. The Competition

Export

Metric	Fresenius Medical Care AG & Co. KGaA	MED INSTRUMENTS Industry	Medical Sector	NYSE Exchange
Market Cap	$11.95B	$6.81B	$6.34B	$22.90B
Dividend Yield	2.66%	1.74%	2.80%	4.09%
P/E Ratio	11.31	50.22	20.66	30.78
Price / Sales	0.54	73.63	547.02	95.02
Price / Cash	3.84	24.26	43.26	25.31
Price / Book	0.72	6.61	9.93	4.67
Net Income	$1.11B	$158.34M	$3.55B	$1.06B
7 Day Performance	-2.40%	-1.17%	1.69%	-0.89%
1 Month Performance	-5.91%	-3.01%	0.48%	1.42%
1 Year Performance	-24.37%	-2.36%	39.38%	24.64%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FMS Fresenius Medical Care AG & Co. KGaA	4.876 of 5 stars	$21.49 +0.5%	$28.00 +30.3%	-22.8%	$11.95B	$22.20B	11.31	1,488	Gap Down
NTRA Natera	3.6684 of 5 stars	$211.56 +2.1%	$253.47 +19.8%	+30.1%	$29.50B	$2.31B	N/A	6,140	Analyst Forecast
GH Guardant Health	3.3405 of 5 stars	$91.17 +4.1%	$128.63 +41.1%	+142.3%	$11.61B	$982.02M	N/A	2,506	Analyst Forecast Insider Trade
BTSG BrightSpring Health Services	3.5395 of 5 stars	$53.54 +1.8%	$54.64 +2.1%	+148.6%	$10.16B	$12.91B	37.97	23,500
HIMS Hims & Hers Health	4.2278 of 5 stars	$27.25 -0.6%	$32.53 +19.4%	-60.8%	$6.25B	$2.35B	53.43	2,442	Trending News Earnings Report Analyst Forecast Options Volume Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. NTRA, GH, BTSG, HIMS, and CELC

How does Fresenius Medical Care AG & Co. KGaA compare to Natera?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Hims & Hers Health?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Celcuity?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

FMS vs. NTRA, GH, BTSG, HIMS, and CELC

How does Fresenius Medical Care AG & Co. KGaA compare to Natera?

Which has more risk & volatility, FMS or NTRA?

Do institutionals and insiders have more ownership in FMS or NTRA?

Does the media refer more to FMS or NTRA?

Is FMS or NTRA more profitable?

Do analysts rate FMS or NTRA?

Which has better valuation and earnings, FMS or NTRA?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Which has more risk & volatility, FMS or GH?

Do institutionals and insiders have more ownership in FMS or GH?

Does the media refer more to FMS or GH?

Is FMS or GH more profitable?

Do analysts rate FMS or GH?

Which has better valuation and earnings, FMS or GH?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

Does the media prefer BTSG or FMS?

Which has stronger earnings & valuation, BTSG or FMS?

Is BTSG or FMS more profitable?

Which has more risk & volatility, BTSG or FMS?

Do analysts prefer BTSG or FMS?

Do insiders & institutionals hold more shares of BTSG or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Hims & Hers Health?

Does the media favor HIMS or FMS?

Which has more volatility and risk, HIMS or FMS?

Which has preferable earnings and valuation, HIMS or FMS?

Is HIMS or FMS more profitable?

Do analysts prefer HIMS or FMS?

Do institutionals & insiders hold more shares of HIMS or FMS?

Summary

How does Fresenius Medical Care AG & Co. KGaA compare to Celcuity?

Does the media favor CELC or FMS?

Which has more volatility and risk, CELC or FMS?

Which has preferable earnings and valuation, CELC or FMS?

Is CELC or FMS more profitable?

Do analysts prefer CELC or FMS?

Do institutionals & insiders hold more shares of CELC or FMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FMS vs. The Competition

Fresenius Medical Care AG & Co. KGaA Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools